INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 142 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $356,452 | -20.4% | 11,273 | +2.7% | 0.00% | 0.0% |
Q2 2023 | $447,724 | +21.3% | 10,979 | +10.9% | 0.00% | 0.0% |
Q1 2023 | $369,010 | -0.8% | 9,901 | -7.1% | 0.00% | 0.0% |
Q4 2022 | $372,032 | -44.3% | 10,663 | -10.7% | 0.00% | -33.3% |
Q3 2022 | $668,000 | +21.2% | 11,943 | +12.2% | 0.00% | 0.0% |
Q2 2022 | $551,000 | -23.3% | 10,642 | +7.8% | 0.00% | 0.0% |
Q1 2022 | $718,000 | -44.4% | 9,875 | -9.6% | 0.00% | -40.0% |
Q4 2021 | $1,292,000 | -12.6% | 10,925 | -0.9% | 0.01% | -28.6% |
Q3 2021 | $1,479,000 | -7.9% | 11,026 | +11.1% | 0.01% | 0.0% |
Q2 2021 | $1,606,000 | +90.3% | 9,920 | -5.7% | 0.01% | +75.0% |
Q1 2021 | $844,000 | -41.6% | 10,520 | -60.4% | 0.00% | -33.3% |
Q4 2020 | $1,444,000 | +167.4% | 26,545 | -2.2% | 0.01% | +200.0% |
Q3 2020 | $540,000 | -4.6% | 27,145 | +0.8% | 0.00% | -33.3% |
Q2 2020 | $566,000 | +69.5% | 26,920 | -1.3% | 0.00% | +50.0% |
Q1 2020 | $334,000 | – | 27,270 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 1,615,321 | $23,697,000 | 41.29% |
ARK Investment Management | 8,741,432 | $128,237,000 | 3.23% |
Nikko Asset Management Americas, Inc. | 7,178,520 | $105,309,000 | 1.66% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $1,635,000 | 0.86% |
Elmwood Wealth Management, Inc. | 64,204 | $942,000 | 0.82% |
361 CAPITAL LLC | 94,772 | $1,390,000 | 0.38% |
Artal Group S.A. | 199,700 | $2,930,000 | 0.11% |
StoneX Group Inc. | 14,982 | $220,000 | 0.09% |
Sumitomo Mitsui Trust Holdings, Inc. | 7,178,520 | $105,309,000 | 0.08% |
PDT Partners, LLC | 85,517 | $1,255,000 | 0.08% |